DPP4 and lung carcinoma: Since ARV p17 has been proven to exert anti-carcinogenic activity on human lung cancer cells, amongst others [10], we wondered whether the viral protein could also be active on human microvascular endothelial cells of lung origin (HMVECs) and whether also in this case, its effects were mediated by DPP4.